169 related articles for article (PubMed ID: 29376491)
1. Ganglioside GM3 and Its Role in Cancer.
Zheng C; Terreni M; Sollogoub M; Zhang Y
Curr Med Chem; 2019; 26(16):2933-2947. PubMed ID: 29376491
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies.
Zhang J; Terreni M; Liu F; Sollogoub M; Zhang Y
Biomed Pharmacother; 2024 Jul; 176():116824. PubMed ID: 38820973
[TBL] [Abstract][Full Text] [Related]
4. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
5. Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.
Margheri F; Papucci L; Schiavone N; D'Agostino R; Trigari S; Serratì S; Laurenzana A; Biagioni A; Luciani C; Chillà A; Andreucci E; Del Rosso T; Margheri G; Del Rosso M; Fibbi G
J Cell Mol Med; 2015 Jan; 19(1):113-23. PubMed ID: 25313007
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling.
Wang XQ; Sun P; Go L; Koti V; Fliman M; Paller AS
J Invest Dermatol; 2006 Dec; 126(12):2687-96. PubMed ID: 16826166
[TBL] [Abstract][Full Text] [Related]
7. Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity.
Guthmann MD; Bitton RJ; Carnero AJ; Gabri MR; Cinat G; Koliren L; Lewi D; Fernandez LE; Alonso DF; Gómez DE; Fainboim L
J Immunother; 2004; 27(6):442-51. PubMed ID: 15534488
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction.
Rebbaa A; Hurh J; Yamamoto H; Kersey DS; Bremer EG
Glycobiology; 1996 Jun; 6(4):399-406. PubMed ID: 8842703
[TBL] [Abstract][Full Text] [Related]
9. GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
Labrada M; Dorvignit D; Hevia G; Rodríguez-Zhurbenko N; Hernández AM; Vázquez AM; Fernández LE
Semin Oncol; 2018 Jan; 45(1-2):41-51. PubMed ID: 30318083
[TBL] [Abstract][Full Text] [Related]
10. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
Gabri MR; Ripoll GV; Alonso DF; Gómez DE
J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.
Dorvignit D; Boligan KF; Relova-Hernández E; Clavell M; López A; Labrada M; Simon HU; López-Requena A; Mesa C; von Gunten S
Sci Rep; 2019 Jul; 9(1):9921. PubMed ID: 31289278
[TBL] [Abstract][Full Text] [Related]
12. [Homeostatic and Pathophysiological Regulation of Toll-like Receptor 4 Signaling by GM3 Ganglioside Molecular Species].
Kanoh H
Yakugaku Zasshi; 2022; 142(3):195-203. PubMed ID: 35228371
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance as a membrane microdomain disorder.
Inokuchi J
Yakugaku Zasshi; 2007 Apr; 127(4):579-86. PubMed ID: 17409686
[TBL] [Abstract][Full Text] [Related]
14. Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes.
Sorice M; Longo A; Garofalo T; Mattei V; Misasi R; Pavan A
Glycoconj J; 2004; 20(1):63-70. PubMed ID: 14993837
[TBL] [Abstract][Full Text] [Related]
15. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS
Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway.
Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K
J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442
[TBL] [Abstract][Full Text] [Related]
17. Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase.
Murozuka Y; Watanabe N; Hatanaka K; Hakomori SI
Glycoconj J; 2007 Dec; 24(9):551-63. PubMed ID: 17638075
[TBL] [Abstract][Full Text] [Related]
18. Effect of synthetic sialyl 2-->1 sphingosine and other glycosylsphingosines on the structure and function of the "glycosphingolipid signaling domain (GSD)" in mouse melanoma B16 cells.
Zhang Y; Iwabuchi K; Nunomura S; Hakomori S
Biochemistry; 2000 Mar; 39(10):2459-68. PubMed ID: 10704195
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.
Yoon SJ; Nakayama K; Hikita T; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18987-91. PubMed ID: 17142315
[TBL] [Abstract][Full Text] [Related]
20. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
